Low-dose Radiotherapy for COVID-19 Pneumonia Treatment: Case Report, Procedure, and Literature Review

Overview

Journal Strahlenther Onkol

Specialties Oncology
Radiology

Date 2020 Aug 21

PMID 32816059

Citations 17

Authors

Ruben Del Castillo

David Martinez

Gustavo J Sarria

Luis Pinillos

Bertha Garcia

Luis Castillo

Alicia Carhuactocto

Frank A Giordano

Gustavo R Sarria

Affiliations

Soon will be listed here.

Abstract

Background: The COVID-19 pandemic outbreak has set the emergency services in developing countries on major alert, as the installed response capacities are easily overwhelmed by the constantly increasing high demand. The deficit of intensive care unit beds and ventilators in countries like Peru is forcing practitioners to seek preventive or early interventional strategies to prevent saturating these chronically neglected facilities.

Case Presentation: A 64-year-old patient is reported after presenting with COVID-19 pneumonia and rapidly progressing to deteriorated ventilatory function. Compassionate treatment with a single 1‑Gy dose to the bilateral whole-lung volume was administered, with gradual daily improvement of ventilatory function and decrease in serum inflammatory markers and oxygen support needs, including intubation. No treatment-related toxicity developed. Procedures of transport, disinfection, and treatment planning and delivery are described.

Conclusion: Whole-lung low-dose radiotherapy seems to be a promising approach for avoiding or delaying invasive respiratory support. Delivered low doses are far from meeting toxicity ranges. On-going prospective trials will elucidate the effectiveness of this approach.

Citing Articles

Radiotherapy for non-cancer diseases: benefits and long-term risks.

Thariat J, Little M, Zablotska L, Samson P, OBanion M, Leuraud K Int J Radiat Biol. 2024; 100(4):505-526.

PMID: 38180039 PMC: 11039429. DOI: 10.1080/09553002.2023.2295966.

COVID-19 and tuberculosis coinfection: An overview of case reports/case series and meta-analysis of prevalence studies.

Daneshvar P, Hajikhani B, Sameni F, Noorisepehr N, Zare F, Bostanshirin N Heliyon. 2023; 9(2):e13637.

PMID: 36789387 PMC: 9911156. DOI: 10.1016/j.heliyon.2023.e13637.

Radiotherapy during the COVID-19: a review about management and treatment strategies.

Bernabucci L, Cornacchione P, Boldrini L, Pasini D, Dinapoli L, Smiljanic L Rep Pract Oncol Radiother. 2022; 27(2):291-302.

PMID: 36299388 PMC: 9591022. DOI: 10.5603/RPOR.a2022.0032.

Covid-19 and radiotherapy: a systematic review after 2 years of pandemic.

Piras A, Venuti V, DAviero A, Cusumano D, Pergolizzi S, Daidone A Clin Transl Imaging. 2022; 10(6):611-630.

PMID: 35910079 PMC: 9308500. DOI: 10.1007/s40336-022-00513-9.

Effect of Low-Dose Radiotherapy on the Circulating Levels of Paraoxonase-1-Related Variables and Markers of Inflammation in Patients with COVID-19 Pneumonia.

Rodriguez-Tomas E, Acosta J, Torres-Royo L, de Febrer G, Baiges-Gaya G, Castane H Antioxidants (Basel). 2022; 11(6).

PMID: 35740079 PMC: 9220239. DOI: 10.3390/antiox11061184.

References

Bentzen S, Constine L, Deasy J, Eisbruch A, Jackson A, Marks L . Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys. 2010; 76(3 Suppl):S3-9. PMC: 3431964. DOI: 10.1016/j.ijrobp.2009.09.040. View

Beitler J, Malhotra A, Thompson B . Ventilator-induced Lung Injury. Clin Chest Med. 2016; 37(4):633-646. PMC: 5131805. DOI: 10.1016/j.ccm.2016.07.004. View

Skipper C, Pastick K, Engen N, Bangdiwala A, Abassi M, Lofgren S . Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial. Ann Intern Med. 2020; 173(8):623-631. PMC: 7384270. DOI: 10.7326/M20-4207. View

Zhao Q, Meng M, Kumar R, Wu Y, Huang J, Deng Y . Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis. Int J Infect Dis. 2020; 96:131-135. PMC: 7196544. DOI: 10.1016/j.ijid.2020.04.086. View

Torres-Roman J, Kobiak I, Valcarcel B, Diaz-Velez C, La Vecchia C . The reproductive number R0 of COVID-19 in Peru: An opportunity for effective changes. Travel Med Infect Dis. 2020; 37:101689. PMC: 7194686. DOI: 10.1016/j.tmaid.2020.101689. View

Rosenberg E, Dufort E, Udo T, Wilberschied L, Kumar J, Tesoriero J . Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State. JAMA. 2020; 323(24):2493-2502. PMC: 7215635. DOI: 10.1001/jama.2020.8630. View

Christofidou-Solomidou M, Pietrofesa R, Arguiri E, Schweitzer K, Berdyshev E, McCarthy M . Space radiation-associated lung injury in a murine model. Am J Physiol Lung Cell Mol Physiol. 2014; 308(5):L416-28. PMC: 4346772. DOI: 10.1152/ajplung.00260.2014. View

Suzuki G, Ogata T, Aibe N, Yamazaki H, Yagyu S, Iehara T . Effective heart-sparing whole lung irradiation using volumetric modulated arc therapy: a case report. J Med Case Rep. 2019; 13(1):277. PMC: 6717977. DOI: 10.1186/s13256-019-2209-2. View

Fryer C, Fitzpatrick P, Rider W, Poon P . Radiation pneumonitis: experience following a large single dose of radiation. Int J Radiat Oncol Biol Phys. 1978; 4(11-12):931-6. DOI: 10.1016/0360-3016(78)90002-0. View

10.

Dubin I, Baylin G, GOBBLE Jr W . The effect of roentgen therapy on experimental virus pneumonia; on pneumonia produced in white mice by swine influenza virus. Am J Roentgenol Radium Ther. 2010; 55:478-81. View

11.

Marks L, Bentzen S, Deasy J, Kong F, Bradley J, Vogelius I . Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys. 2010; 76(3 Suppl):S70-6. PMC: 3576042. DOI: 10.1016/j.ijrobp.2009.06.091. View

12.

Calabrese E, Dhawan G, Kapoor R, Kozumbo W . Radiotherapy treatment of human inflammatory diseases and conditions: Optimal dose. Hum Exp Toxicol. 2019; 38(8):888-898. DOI: 10.1177/0960327119846925. View

13.

Arpin D, Perol D, Blay J, Falchero L, Claude L, Vuillermoz-Blas S . Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis. J Clin Oncol. 2005; 23(34):8748-56. DOI: 10.1200/JCO.2005.01.7145. View

14.

Tang W, Cao Z, Han M, Wang Z, Chen J, Sun W . Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial. BMJ. 2020; 369:m1849. PMC: 7221473. DOI: 10.1136/bmj.m1849. View

15.

Frey B, Gaipl U, Sarter K, Zaiss M, Stillkrieg W, Rodel F . Whole body low dose irradiation improves the course of beginning polyarthritis in human TNF-transgenic mice. Autoimmunity. 2009; 42(4):346-8. DOI: 10.1080/08916930902831738. View

16.

Papachristofilou A, Hottinger A, Weinhold O, Avcu Y, Finazzi T, Diesch T . Heart-sparing volumetric modulated arc therapy for whole lung irradiation. Strahlenther Onkol. 2018; 195(1):77-82. DOI: 10.1007/s00066-018-1363-6. View

17.

Kalapurakal J, Lee B, Bautista J, Rigsby C, Helenowski I, Gopalakrishnan M . Cardiac-Sparing Whole Lung Intensity Modulated Radiation Therapy in Children With Wilms Tumor: Final Report on Technique and Abdominal Field Matching to Maximize Normal Tissue Protection. Pract Radiat Oncol. 2018; 9(1):e62-e73. DOI: 10.1016/j.prro.2018.07.005. View

18.

Tapio S . Pathology and biology of radiation-induced cardiac disease. J Radiat Res. 2016; 57(5):439-448. PMC: 5045085. DOI: 10.1093/jrr/rrw064. View

19.

Rodel F, Arenas M, Ott O, Fournier C, Georgakilas A, Tapio S . Low-dose radiation therapy for COVID-19 pneumopathy: what is the evidence?. Strahlenther Onkol. 2020; 196(8):679-682. PMC: 7211051. DOI: 10.1007/s00066-020-01635-7. View

20.

Gattinoni L, Chiumello D, Rossi S . COVID-19 pneumonia: ARDS or not?. Crit Care. 2020; 24(1):154. PMC: 7160817. DOI: 10.1186/s13054-020-02880-z. View